OakChart

Trulieve Cannabis Corp

TRLVHealthcare·Drug Manufacturers - Specialty & Generic·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

11.23+0.14 (1.26%)
2026-11-12 05:51 CET
Market cap
2,162.51 USD m
Revenue, TTM
1,081.07 USD m
Net income, TTM
-445.60 USD m
Free cash flow, TTM
172.14 USD m
EPS diluted, TTM
-2.31
P/E
-
Compare

Price

TRLV against its 20, 50 and 200-day averages
2050200miss
8.0010.0012.006.4M12.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TRLVclose 11.2320-day 10.8450-day 11.17200-day 8.9411.2352w high

15.4% under the 52-week high of 13.28 on 9 Jun 2026. 52-week low 4.62 on 19 Nov 2025. Last 15 sessions, 21.7% high to low

Volume 0.66× normal · the line is the 50-bar volume average

Profile

TRLV
52-week range, 76% of the way up
4.6213.28

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Employees5000
IPOSep 27, 2018
Beta1.91
ATR, 14d0.71
Rel volume0.66
Short float2.36%
Insider own15.55%
Inst own17.94%

Snapshot

6 groups

Valuation

Index-
Market Cap2.16B
Enterprise Value2.42B
Income-445.60M
Sales1.08B
Book/sh4.01
Cash/sh1.70
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees5000
IPOSep 27, 2018

Ratios

P/E-
Forward P/E32.09
PEG-
P/S2.00
P/B2.80
P/C6.62
P/FCF12.56
EV/EBITDA7.56
EV/Sales2.24
Quick Ratio3.65
Current Ratio5.52
Debt/Eq0.75
LT Debt/Eq0.72
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.31
EPS next Y0.35
EPS next Q0.02
EPS this Y-230.49%
EPS next Y117.36%
EPS next 5Y-
EPS past 3/5Y22.54% -
Sales past 3/5Y-1.02% 17.76%
EPS Y/Y TTM-230.91%
Sales Y/Y TTM-9.09%
EPS Q/Q103.06%
Sales Q/Q-20.12%
EarningsNov 05 BMO
EPS/Sales Surpr.-100.00% 3.75%

Ownership

Insider Own15.55%
Insider Trans-5.37%
Inst Own17.94%
Inst Trans25.93%
ROA-17.60%
ROE-45.04%
ROIC-33.56%
Gross Margin51.15%
Oper. Margin15.08%
Profit Margin-41.22%
SMA203.63%
SMA500.51%
SMA20025.68%
Trades-

Technical

Shs Outstand170.35M
Shs Float162.61M
Short Float2.36%
Short Ratio2.16
Short Interest3.84M
52W High13.28 -15.44%
52W Low4.62 143.28%
Volatility6.47% 6.57%
ATR (14)0.71
RSI (14)53.24
Beta1.91
Rel Volume0.66
Avg Volume1.78M
Volume1,165,667

Performance

Perf Week-3.19%
Perf Month11.08%
Perf Quarter16.98%
Perf Half Y35.14%
Perf YTD29.23%
Perf Year61.82%
Perf 3Y107.96%
Perf 5Y-61.09%
Perf 10Y-
Recom1.00
Target Price18.32
Prev Close11.09
Price11.23
Change %1.26%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Jul 20, 2026InitiatedCCantor FitzgeraldOverweight$15+33.6%

Peers

Mkt cap
TickerCompanyMkt cap
GLASGlass House Brands Inc144.79M
CRONCronos Group Inc1.26B
CGCCanopy Growth Corp256.13M
TLRYTilray Brands Inc385.73M
ACBAurora Cannabis Inc331.99M
OGIOrganigram Global Inc120.38M
HITIHigh Tide Inc225.52M
IIPRInnovative Industrial Properties Inc1.51B
VFFVillage Farms International Inc329.04M
SNDLSNDL Inc345.52M

Insider trading

8 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Rivers Kim A.Chairman and CEOJun 26 '26Sale8.76136,8111,197,9171,476,913Jun 26 04:38 PM
Rivers Kim A.Chairman and CEOJun 24 '26Sale8.17400,0003,267,6001,913,724Jun 25 07:42 PM
Rivers Kim A.Chairman and CEOJun 23 '26Sale8.47380,0003,218,2202,313,724Jun 25 07:42 PM
Rivers Kim A.Chairman and CEOJun 25 '26Sale8.17300,0002,450,7001,613,724Jun 25 07:42 PM
Rivers Kim A.Chairman and CEOJun 22 '26Sale9.35204,8151,915,8402,693,724Jun 22 06:04 PM
Rivers Kim A.Chairman and CEOJun 18 '26Sale9.46139,8461,322,9432,898,539Jun 22 06:04 PM
Rivers Kim A.Chairman and CEOJun 17 '26Sale9.36137,5351,287,1903,038,385Jun 22 06:04 PM
Rivers Kim A.OfficerJun 17 '26Proposed Sale10.501,699,00717,839,574Jun 17 09:45 AM

Held by

AUM
TickerCompanyAUM
MSOSAdvisorShares Pure US Cannabis ETFAUM: 754.58M
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
CNBSAmplify Seymour Cannabis ETFAUM: 64.64M
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
YOLOAdvisorShares Pure Cannabis ETFAUM: 30.85M
FYXFirst Trust Small Cap Core AlphaDEX FundAUM: 1.39B
ITOTiShares Core S&P Total U.S. Stock Market ETFAUM: 95.28B
SCHBSchwab U.S. Broad Market ETFAUM: 44.09B

News

latest 14 of 27
  • Trulieve Announces November 2026 Event Participation (PR Newswire)
  • Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia (PR Newswire)
  • Trulieve Reports Third Quarter 2026 Results (PR Newswire) -6.03%
  • Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations (PR Newswire) +7.98%
  • Trulieve's Rally Meets A Cautious Street Model That Expects Sharply Lower Sales (Earnings Whispers)
  • Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet (PR Newswire)
  • Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026 (PR Newswire)
  • Cannabis Stocks Are Slumping. A Procedural DEA Delay Is to Blame. (Barrons.com) -12.17%
  • Trulieve Sinks 14% as DEA Judge Pauses Cannabis Rescheduling Over GAO Report Flagging Gaps (TIKR)
  • MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case (Stocktwits)
  • Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas (PR Newswire)
  • Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices (PR Newswire) +8.43%
  • Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia (PR Newswire)
  • Trulieve Announces September 2026 Event Participation (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.0000.0930.000230.2221.884
2026Q22026-08-07-2.1100.086-2.107271268.543
2026Q12026-05-070.010-0.0140.012286.8284.694
2025Q42026-02-26-0.020--0.224293.1--
2025Q32025-11-05-0.070--0.140288.2--
2025Q22025-08-06-0.040--0.072302.1--
2025Q12025-05-07-0.020--0.172297.8--
2024Q42025-02-270.020--0.315301.1--
2024Q32024-11-05-0.060--0.327284.3--
2024Q22024-08-060.000--0.073303.4--
2024Q12024-05-09-0.050--0.168298--
2023Q42024-02-29-0.120--0.177287--
2023Q32023-11-09-0.080--0.134275.2--
2023Q22023-08-09-0.080--2.136281.8--
2023Q12023-05-10---0.340289.1--
2022Q42023-03-08---0.408302.2--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-0.610-0.430-0.6101,1811,186
2026FY--2.016--1,023
2027FY-0.350--957.19
2028FY-0.500--936.65
2029FY-0.520--989.1
2030FY-0.530--1,019

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-05660235.08232.4236.11
2026Q4S2026-10-21600227.75221.1231.7
2026Q4S2026-09-13640227.75221.1231.7
2026Q4S2026-08-19641227.75221.1231.7
2026Q4S2026-08-07642227.75221.1231.7
2026Q4S2026-07-24605223.06217.9232.2
2026Q4S2026-07-17605223.06217.9232.2
2026Q4S2026-07-07505223.64217.9232.2
2026Q4S2026-06-30514239.1217.9300.9
2026Q4S2026-06-11513253.3217.9300.9
2026Q4S2026-06-09613261.75217.9304
2026Q4S2026-06-05622273.98219.9304
2026Q4S2026-06-04621286.1219.9304.9
2026Q4S2026-06-03620299.28291.3304.9

Estimate history

EPS, annual0.0330.2710.460.5320.123-1.309-2.788-0.816-0.608-2.3139
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.327-0.315-0.172-0.072-0.14-0.2240.012-2.1070.004
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual19.778102.817252.819521.533937.9811218.2291129.1931186.491181.181081.07
Period201720182019202020212022202320242025TTM
Sales, quarterly284.284301.1297.76302.086288.187293.147286.754270.952230.215
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual109.811110.132110.346119.574180.504185.988186.236191.006192.307192.754
Period201720182019202020212022202320242025MRQ
Shares, quarterly189.154191.006191.077191.101191.145192.307192.307192.383192.754
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,081.071,181.181,186.491,129.191,218.23937.98521.53252.82102.82
Cost of Goods Sold Incl. D&A528.11587.65583.55650.39645.48417.40147.7266.0683.96
Gross Profit552.96593.53602.94478.80572.75520.58373.82186.7618.86
Selling, General and Administrative Excl. Other389.94434.75499.42386.16447.03315.66155.4573.4244.21
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income163.03158.79103.5292.64125.71204.93218.37113.34-25.34
Interest Expense52.7463.4562.1981.5773.4234.7920.249.052.18
Unusual Expense444.4619.7212.94304.371.295.1642.740.00-84.18
Net Income Before Taxes-328.2191.4742.71-284.54-19.24166.09157.45103.6856.71
Income Taxes117.97208.11197.59151.36163.38146.7094.4550.5928.76
Consolidated Net Income-446.18-116.64-154.88-435.90-182.6219.3863.0053.0927.95
Net Income From Continuing Operations-445.17-110.77-149.40-430.75-178.6219.9763.0053.0927.95
Net Income-445.60-116.38-155.11-526.80-246.0618.0363.0053.0927.95
EPS (Recurring)-0.67-0.54-0.77-1.66-1.300.150.790.46-0.30
EPS (Basic, Before Extraordinaries)-2.31-0.61-0.82-2.79-1.310.130.550.480.27
EPS (Diluted)-2.31-0.61-0.82-2.79-1.310.120.530.460.27
EBITDA319.54332.19269.89259.49289.26283.15248.55129.14-22.24
Non-Operating Income (Expense)5.9615.8514.338.76-70.231.112.06-0.610.06
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense16.5316.1715.968.3514.325.462.060.0015.02
Price To Earnings Ratio-----34.8249.369.1119.81
Price To Sales Ratio2.021.410.830.871.174.077.175.408.11
Gross Margin51.1550.2550.8242.4047.0155.5071.6873.8718.34
Operating Margin15.0813.448.728.2010.3221.8541.8744.83-24.65
Net Margin-41.22-9.85-13.07-46.65-20.201.9212.0821.0027.18
Shares Outstanding192.75192.31191.01186.24185.99180.50119.57110.35110.13
Market Capitalization2,162.512,162.51980.67968.991,407.114,848.033,020.701,306.43889.87

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue230.22270.95286.75293.15288.19302.09297.76301.10
Cost of Goods Sold Incl. D&A99.90134.39146.42147.40147.79148.59143.87142.70
Gross Profit130.31136.57140.34145.74140.40153.50153.89158.40
Selling, General and Administrative Excl. Other78.6789.4697.45124.3595.19102.32118.77159.40
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income51.6447.1042.8921.3945.2151.1835.12-1.00
Interest Expense11.9812.7613.3214.6816.0916.3916.3014.60
Unusual Expense9.15417.637.1710.522.97-0.251.79-0.90
Net Income Before Taxes27.03-383.4025.222.9429.3038.9020.33-12.90
Income Taxes26.2521.9721.8647.8953.0454.7252.4647.60
Consolidated Net Income0.77-405.363.36-44.95-23.74-15.82-32.14-60.50
Net Income From Continuing Operations0.87-405.283.48-44.25-21.79-13.49-31.25-58.70
Net Income0.87-405.982.41-42.90-26.84-13.78-32.87-59.80
EPS (Recurring)0.04-0.590.04-0.19-0.13-0.07-0.17-0.32
EPS (Basic, Before Extraordinaries)0.00-2.110.01-0.22-0.14-0.07-0.17-0.31
EPS (Diluted)0.00-2.110.01-0.22-0.14-0.07-0.17-0.31
EBITDA81.6086.2686.6265.0688.6194.3378.3044.30
Non-Operating Income (Expense)-3.49-0.112.826.753.153.863.301.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.665.463.273.144.575.343.113.63
Price To Sales Ratio2.021.660.951.411.300.610.620.83
Gross Margin56.6050.4048.9449.7248.7250.8151.6852.61
Operating Margin22.4317.3814.967.3015.6916.9411.79-0.33
Net Margin0.38-149.830.84-14.63-9.31-4.56-11.04-19.86
Shares Outstanding192.75192.38192.31192.31191.14191.10191.08191.01
Market Capitalization2,162.511,890.381,076.921,661.161,540.36726.09737.28980.67

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments255.53300.10207.98213.79233.10146.7191.8124.431.41
Short Term Receivables20.2023.0512.947.2410.230.310.000.000.00
Inventories242.30231.37213.12276.50209.9498.3165.9853.9111.99
Other Current Assets44.6850.0443.3196.0171.6616.127.682.450.18
Total Current Assets562.72604.56477.35593.54524.93261.45165.4780.7913.58
Net Property, Plant & Equipment838.74899.98830.80912.68957.90381.02185.8870.7919.29
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable0.450.537.4211.9912.150.00---
Intangible Assets1,282.271,343.391,401.101,776.291,846.60159.7733.709.401.00
Deferred Tax Assets57.5560.9145.8440.1632.148.241.990.570.00
Other Assets11.9321.8212.39105.9069.817.530.951.100.00
Total Assets2,753.652,931.182,774.903,440.573,443.52818.02387.99162.6433.87
Short Term Debt Incl. Current Port. of LT Debt30.2426.9922.9332.2027.2521.167.747.762.36
Accounts Payable26.7820.2334.1622.1621.6714.8518.497.114.05
Income Tax Payable--0.0049.6228.085.888.3315.061.14
Other Current Liabilities69.9391.2757.76106.3192.4534.2318.124.780.01
Total Current Liabilities126.94138.49114.85210.29169.4576.1252.6734.717.55
Long Term Debt533.38797.47406.43401.19354.47149.2276.7013.2612.10
Provision for Risks Charges668.38445.22180.3519.460.000.000.000.000.00
Deferred Tax Liabilities235.54257.46252.81265.06274.0223.697.489.723.09
Other Liabilities46.3943.51411.85616.85498.21121.08118.260.720.00
Total Liabilities1,610.641,682.151,366.281,512.861,296.15370.12255.1058.4222.75
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,161.231,261.291,414.471,931.162,145.82447.90132.88104.2211.12
Total Shareholders Equity1,161.231,261.291,414.471,931.162,145.82447.90132.88104.2211.12
Accumulated Minority Interest-18.22-12.26-5.86-3.461.550.000.000.000.00
Total Equity1,143.011,249.031,408.611,927.702,147.37447.90132.88104.2211.12
Total Liabilities & Stockholders Equity2,753.652,931.182,774.903,440.573,443.52818.02387.99162.6433.87
Book Value Per Share6.046.607.6010.3811.893.751.200.950.10
Tangible Book Value Per Share-0.63-0.430.070.831.662.410.900.860.09
Full-Time Employees5,0006,0005,4007,6009,0004,8453,0841,787-
Price to Book Ratio2.800.750.670.704.109.215.528.5410.05
Return on Assets-3.90-5.24-13.75-5.190.9410.4519.2828.4417.31
Return on Equity-9.14-11.17-25.75-8.761.5421.6944.7948.4664.60
Return on Invested Capital-6.87-7.53-28.93-10.550.7210.5525.3323.7915.38
Quick Ratio2.522.692.301.511.862.141.890.770.21
Current Ratio4.434.374.162.823.103.433.142.331.80

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-441.45-122.25-160.58-533.14-252.7317.4563.0053.0927.95
Depreciation153.71173.40166.37177.19174.7878.2230.1915.803.11
Other Funds (Non Cash)447.8646.3233.14400.85183.9428.3648.401.7216.24
Funds from Operations135.7278.9228.5527.7378.8297.76136.6969.7153.35
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital102.15193.90242.93174.11-55.73-84.86-37.05-50.64-28.39
Income Taxes Payable-0.371.55-8.50-48.8219.76-12.98-2.45-6.7413.93
Cash from Operating Activities237.87272.82271.48201.8423.1012.9099.6419.0724.96
Capital Expenditures-65.73-60.51-147.66-55.64-189.07-300.60-141.94-74.41-45.43
Net Assets From Acquisitions0.000.000.000.00-27.780.00-27.92-19.83-7.66
Sale of Fixed Assets and Businesses0.000.000.005.030.7443.490.020.030.13
Purchase or Sale of Investments-0.8060.00-60.000.000.000.000.000.000.00
Purchase of Investments0.000.00-80.000.000.000.000.000.000.00
Sale Or Maturity of Investments-0.8060.0020.000.000.000.000.000.000.00
Other Uses-57.79-0.12-7.65-0.75-4.73-13.23-4.80-0.470.00
Other Sources6.1114.138.7013.895.7855.160.000.000.00
Cash from Investing Activities-161.3213.50-206.62-37.47-215.06-215.18-174.65-94.67-52.96
Cash Dividends Paid0.000.000.00-0.05-0.050.000.000.000.00
Change in Capital Stock0.000.000.000.0019.39225.9294.690.9648.96
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.0019.39225.9294.690.9648.96
Proceedsfrom Stock Options0.000.000.000.000.00217.9083.230.0047.47
Issuance or Reduction of Debt, Net-195.36-256.63-8.1510.11168.3064.6435.22143.652.52
Change in Long Term Debt-195.36-256.63-8.1510.11168.3064.6435.22143.652.52
Issuance of Long Term Debt195.84136.720.0023.94172.39361.8741.12145.2911.20
Reduction of Long Term Debt-391.20-393.35-8.15-13.83-4.09-297.23-5.89-1.64-8.68
Net Financing Active Other Cash Flow-16.17-13.87-25.29-178.06-2.49-1.070.000.000.00
Other Financing Activities Uses-16.53-13.87-28.50-178.06-2.49-1.070.000.000.00
Cash from Financing Activities-211.52-270.50-33.44-175.59177.80289.23129.91142.9851.02
Net Change in Cash-134.9715.8331.43-11.21-14.1786.9554.9067.3823.02
Free Cash Flow172.14228.63148.88161.46-154.90-283.98-41.41-55.33-20.47
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow12.707.276.616.10-----
Deferred Taxes & Investment Tax Credit--18.55-10.37-17.17-27.17-26.26-4.89-0.916.06

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments326.69325.42352.88255.53450.11400.99
Short Term Receivables25.5827.1122.1320.2019.4421.16
Inventories190.83186.87242.32242.30243.29241.46
Other Current Assets19.6925.4335.6344.6843.6147.77
Total Current Assets562.78564.83652.96562.72756.45711.38
Net Property, Plant & Equipment738.72724.88851.97838.74865.61881.14
Total Investments and Advances146.07152.500.000.007.500.00
Intangible Assets660.66626.071,264.651,282.271,299.211,316.28
Deferred Tax Assets---57.55--
Other Assets9.638.7011.9111.9312.3212.51
Total Assets2,118.242,077.432,781.952,753.652,941.622,921.84
Short Term Debt Incl. Current Port. of LT Debt27.5326.2431.1730.2429.2328.71
Accounts Payable68.1961.4978.9382.6681.2879.04
Other Current Liabilities6.257.3214.0614.0513.6216.08
Total Current Liabilities101.9795.06124.16126.94124.13123.84
Long Term Debt554.67551.02597.52533.38783.84794.98
Provision for Risks Charges625.37598.19696.39668.38616.32559.66
Deferred Tax Liabilities55.3957.25169.78235.54181.88186.63
Other Liabilities9.3110.0144.7646.3949.1847.25
Total Liabilities1,346.701,311.531,632.621,610.641,755.341,712.36
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity773.19767.461,167.781,161.231,203.801,225.05
Total Shareholders Equity773.19767.461,167.781,161.231,203.801,225.05
Accumulated Minority Interest-1.65-1.55-18.45-18.22-17.53-15.58
Total Equity771.54765.911,149.331,143.011,186.281,209.47
Total Liabilities & Stockholders Equity2,118.242,077.432,781.952,753.652,941.622,921.84
Book Value Per Share4.013.996.076.046.306.41
Tangible Book Value Per Share0.580.73-0.50-0.63-0.50-0.48
Full-Time Employees---5,000--
Price to Book Ratio2.801.620.931.381.260.59
Return on Assets-17.60-18.72-2.68-3.90-4.31-5.67
Return on Equity-45.04-46.96-6.34-9.14-9.95-12.60
Return on Invested Capital0.07-30.790.14-2.53-1.35-0.68
Quick Ratio3.653.983.312.524.133.79
Current Ratio5.525.945.264.436.095.74

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income3.09-404.182.28-42.64-29.11-16.99
Depreciation29.1738.7743.7342.0443.8844.67
Other Funds (Non Cash)12.77417.077.0510.9712.2612.46
Funds from Operations43.3040.9044.856.6622.2334.70
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital29.7211.7310.8549.8555.4253.81
Income Taxes Payable-0.34-0.611.71-1.12--
Cash from Operating Activities73.0252.6355.7156.5177.6488.51
Capital Expenditures-68.10-20.85-13.48-6.41-16.77-16.66
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.00-0.80-0.541.06
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.00-0.80-0.541.06
Other Uses0.34-58.120.000.000.09-0.00
Other Sources0.254.520.301.041.527.58
Cash from Investing Activities-67.52-74.45-13.19-6.16-15.70-8.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.23-1.9557.41-249.59-2.03-3.69
Change in Long Term Debt-1.23-1.9557.41-249.59-2.03-3.69
Issuance of Long Term Debt-0.34-0.2859.46137.010.000.00
Reduction of Long Term Debt-0.88-1.68-2.05-386.59-2.03-3.69
Net Financing Active Other Cash Flow-3.43-4.01-2.58-6.14-2.79-2.33
Other Financing Activities Uses-3.79-4.01-2.58-6.14-2.79-2.33
Cash from Financing Activities-4.65-5.9754.83-255.73-4.82-6.02
Net Change in Cash0.85-27.7897.35-205.3857.1274.47
Free Cash Flow44.5031.7842.2253.6365.1976.44
Price to Free Cash Flow12.709.824.667.279.648.07

Revenue breakdown

Retail2024: 1.13B 2025: 1.11B
Wholesale and Other2024: 57.61M 2025: 70.74M
United States2024: 1.19B 2025: 1.18B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.36%3.8M162.6M1.68M
2026-10-154.46%7.3M162.6M1.62M
2026-09-303.96%6.4M162.6M1.54M
2026-09-153.15%5.1M162.6M1.31M
2026-08-310.89%1.4M162.6M1.28M
2026-08-140.82%1.3M162.3M1.14M
2026-07-310.82%1.3M162.0M1.07M
2026-07-151.07%1.7M163.5M1.09M
2026-06-300.50%0.8M163.5M946.74K
2026-06-150.18%0.3M162.4M623.56K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.507.4010.008.2214.4501.000.000.963-0.0680.001
call5.004.907.500.007.9130.000.000.926-0.0680.002
call6.004.805.800.004.8480.000.000.907-0.0660.003
call7.503.104.404.003.55367.000.000.870-0.0600.004
call9.001.053.602.553.7626.000.000.813-0.0520.005
call10.000.901.901.651.8081791.000.745-0.0430.006
call11.000.451.001.001.27920421.000.581-0.0540.007
call12.500.100.350.251.1381,34689.000.303-0.0400.006
call14.000.000.200.011.3533230.000.173-0.0340.004
call15.000.000.100.131.3361,50530.000.099-0.0230.003
call16.000.000.650.101.54518.000.000.088-0.0250.003
call17.500.001.550.051.82466.000.000.078-0.0260.003
call19.000.000.650.002.0690.000.000.070-0.0280.002
call20.000.000.850.052.21842.000.000.067-0.0280.002
call21.000.000.650.002.3570.000.000.064-0.0290.002
call22.500.000.250.052.55030.000.000.060-0.0300.002
put2.500.001.150.008.5920.000.00-0.037-0.0680.001
put5.000.000.850.004.8880.000.00-0.074-0.0680.002
put6.000.000.650.003.9780.000.00-0.093-0.0650.003
put7.500.000.500.052.8651670.00-0.130-0.0600.004
put9.000.000.650.411.92731.000.00-0.187-0.0510.005
put10.000.150.400.221.3442552.00-0.255-0.0420.006
put11.000.200.900.701.47129.000.00-0.419-0.0530.007
put12.501.202.002.481.7282320.00-0.697-0.0380.006
put14.002.453.300.001.9810.000.00-0.827-0.0330.004
put15.003.404.500.002.6220.000.00-0.901-0.0210.003
put16.004.305.600.003.0660.000.00-0.912-0.0230.003
put17.504.808.400.005.1230.000.00-0.922-0.0240.003
put19.006.609.700.005.4720.000.00-0.930-0.0260.002
put20.007.6010.600.005.5340.000.00-0.933-0.0260.002
put21.008.6011.700.005.8770.000.00-0.936-0.0270.002
put22.5010.1013.100.005.9960.000.00-0.940-0.0280.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-08-24S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-08-24POSASRPost-effective amendment to an automatic shelf registration statement of Form S-3ASR or Form F-3ASRSEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-078-KCurrent report2026-08-07SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-08SCHEDULE 13GSEC
2026-07-028-KCurrent report2026-06-30SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-25DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-25DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-25SEC
2026-06-254Statement of changes in beneficial ownership of securities2026-06-23SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-17144Filing for proposed sale of securities under Rule 144.SEC
2026-06-12PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-08SEC
2026-06-128-KCurrent report2026-06-11SEC
2026-06-118-KCurrent report2026-06-09SEC
2026-06-098-KCurrent report2026-06-09SEC
2026-06-098-A12BSEC
2026-06-09CERTSEC
2026-06-048-KCurrent report2026-06-03SEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-29DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-29ARSAnnual report to security holders. 2025-12-31SEC
2026-04-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-31SEC
2026-04-218-KCurrent report2026-04-15SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060014.66M7
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
AdvisorShares Investments LLC5.46%
CANTOR FITZGERALD, L. P.3.90%
NOMURA HOLDINGS INC2.63%
Marex Group Ltd1.69%
ING GROEP NV1.38%
OAKMONT Corp0.78%
JANE STREET GROUP, LLC0.63%
iA Global Asset Management Inc.0.45%
PICTON MAHONEY ASSET MANAGEMENT0.34%
Anson Funds Management LP0.27%

Funds

Fund% owned
Intrepid Income Fund13.73%
AdvisorShares Pure US Cannabis ETF5.30%
RiverPark Strategic Income Fund4.23%
Intrepid Capital Fund1.20%
AdvisorShares Pure Cannabis ETF0.24%
Small Cap Value Fund0.03%
TIFF MULTI-ASSET FUND0.02%
Roundhill Cannabis ETF0.00%
Amplify Seymour Cannabis ETF0.00%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. TRLV. Cached 15 minutes.